Is Brainstorm Cell Therapeutics Inc. (BCLI) a Buy, Sell, or Hold?
OTC : BCLI
Brainstorm Cell Therapeutics Inc. — Competitors
$0.79 USD
$0.0 (0.31%)
- Volume
- 5.38K
- Average Volume
- 16.89K
- Market Capitalization
- $8.72M
- P/E Ratio
- -0.84
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $1.69
- Year Low
- $0.46
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.02
BCLI vs. The Competition
| Properties | BCLI | ACXP | ADIL | ADXN |
|---|---|---|---|---|
| Market Cap | $8.72M | $6.58M | $4.04M | $7.33M |
| Shares Outstanding | $11.03M | $4.3M | $959.64K | $1.23M |
| P/E Ratio | -0.84 | -0.31 | -0.43 | -0.71 |
| EPS | -0.87 | -5.0 | -5.67 | -4.88 |
| Day Low | 0.75 | 1.5 | 4.06 | 5.95 |
| Day High | 0.79 | 1.54 | 4.35 | 5.95 |
| Year Low | 0.46 | 1.326 | 1.31 | 5.04 |
| Year High | 1.69 | 8.34 | 10.75 | 12.05 |
| Average Price 50 | 0.916 | 1.5628 | 2.8224 | 6.0068 |
| Average Price 200 | 0.73795 | 2.80665 | 4.02405 | 7.17383 |
| Volume | 5385 | 73983 | 53200 | 2104 |
| Average Volume | - | - | - | - |